Evoke Pharma, Inc.
(NASDAQ : EVOK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 10.38%48.510.0%$558.21m
VRXValeant Pharmaceuticals International, Inc. -1.02%27.2714.1%$160.46m
CTLTCatalent, Inc. -1.56%136.012.0%$156.22m
PRGOPerrigo Co. Plc -1.11%43.796.9%$137.53m
ICLRICON plc -0.94%268.192.8%$117.70m
INDPIndaptus Therapeutics, Inc. -12.95%10.080.0%$111.65m
HZNPHorizon Therapeutics Plc 1.63%109.715.5%$103.63m
JAZZJazz Pharmaceuticals Plc 1.12%133.222.1%$97.67m
ARGXargenx SE 2.50%331.670.0%$60.05m
ENDPEndo International Plc 4.04%2.838.5%$55.42m
AXSMAxsome Therapeutics, Inc. 4.17%29.721.8%$52.84m
UTHRUnited Therapeutics Corp. -2.47%200.0814.0%$50.73m
BHCBausch Health Cos., Inc. -1.02%27.270.0%$49.51m
SNOASonoma Pharmaceuticals, Inc. 0.75%5.353.4%$33.25m
SAGESAGE Therapeutics, Inc. 2.43%46.407.6%$22.43m

Company Profile

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.